New $6M Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing

Genome Canada, the Ontario Institute for Cancer Research (OICR) and Thermo Fisher Scientific are collaborating to develop a complete solution of targeted next generation sequencing (NGS) assays and analysis software designed to more effectively assess cancer.

Click here to learn more

Previous
Previous

RetiSpec Featured on CTV News Toronto

Next
Next

Apply for the Falling Walls Lab Pitch Competition, September 9